# Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research

> **NCT02517957** · PHASE2 · UNKNOWN · sponsor: **Shanghai Yueyang Integrated Medicine Hospital** · enrollment: 342 (estimated)

## Conditions studied

- Eczema

## Interventions

- **DRUG:** Furoic acid loperamide hydrochloride cream
- **DRUG:** Mullite ointment
- **DRUG:** 3% boric acid solution
- **DRUG:** Zine oxide

## Key facts

- **NCT ID:** NCT02517957
- **Lead sponsor:** Shanghai Yueyang Integrated Medicine Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2017-08
- **Final completion:** —
- **Target enrollment:** 342 (ESTIMATED)
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517957, "Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02517957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*